Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -225,680 | -53,224 | -188,863 | -328,405 | -30,143 |
| Depreciation Amortization | 96,861 | 100,150 | 106,519 | 109,816 | 79,501 |
| Income taxes - deferred | -14,999 | 14,744 | 146 | -74,405 | 10,159 |
| Accounts receivable | 30,213 | -220 | 3,411 | 128,602 | 5,232 |
| Accounts payable and accrued liabilities | -14,217 | -20,662 | 2,828 | -9,388 | -10,847 |
| Other Working Capital | -41,180 | 32,175 | 21,799 | 42,654 | -20,482 |
| Other Operating Activity | -9,540 | -256,452 | 25,963 | 35,937 | 4,917 |
| Operating Cash Flow | $-178,542 | $-183,489 | $-28,197 | $-95,189 | $38,337 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 115,423 | 8,079 |
| PPE Investments | -11,991 | -24,768 | -13,562 | -22,627 | 33,870 |
| Net Acquisitions | N/A | N/A | N/A | -1,758 | -4,000 |
| Purchase Of Investment | -7,665 | N/A | -5,000 | N/A | -2,000 |
| Sale Of Investment | 52,182 | 166,604 | 364 | N/A | N/A |
| Other Investing Activity | 197,770 | 210,378 | 0 | 0 | 0 |
| Investing Cash Flow | $230,296 | $352,214 | $-18,198 | $91,038 | $35,949 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 33,033 | 459,432 | 671,678 | 1,059,519 | 1,684,713 |
| Debt Issued | N/A | 480,000 | N/A | N/A | N/A |
| Debt Repayment | -62,382 | -176,389 | -3,000 | N/A | N/A |
| Common Stock Issued | -256 | -208 | -272 | -774 | 1,081 |
| Common Stock Repurchased | -47,040 | -90,223 | N/A | N/A | N/A |
| Other Financing Activity | -41,411 | -488,446 | -679,709 | -1,035,774 | -1,696,144 |
| Financing Cash Flow | $-118,056 | $184,166 | $-11,303 | $22,971 | $-10,350 |
| Exchange Rate Effect | 3,429 | -3,157 | 388 | -339 | -1,437 |
| Beginning Cash Position | 445,615 | 95,881 | 153,191 | 134,710 | 72,211 |
| End Cash Position | 382,742 | 445,615 | 95,881 | 153,191 | 134,710 |
| Net Cash Flow | $-62,873 | $349,734 | $-57,310 | $18,481 | $62,499 |
| Free Cash Flow | |||||
| Operating Cash Flow | -178,542 | -183,489 | -28,197 | -95,189 | 38,337 |
| Capital Expenditure | -12,278 | -25,010 | -16,275 | -24,578 | -32,156 |
| Free Cash Flow | -190,820 | -208,499 | -44,472 | -119,767 | 6,181 |